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Traumatic injuries of the peripheral nerves are very common. Surgical repair of the damaged nerve is often
complicated by scar tissue formation around the damaged nerve itself. The main objective of this study is to
present the recent data from animal experimental studies where pharmacological topical agents are used at the
site of peripheral nerve repair. Some of the most commonly topical agents used are tacrolimus (FK506), hyaluronic acid
and its derivatives, and melatonin, whereas methylprednisolone and vitamin B12 have been used less. These studies
have shown that the abovementioned substances have neuroprotective and neuroregenerative properties though
different mechanisms. The successes of the regenerative process of the nerve repair in experimental research, using
topical agents, can be evaluated using variety of methods such as morphological, electrophysiologic, and functional
evaluation. However, most authors agree that despite good microsurgical repair and topical application of these
substances, full regeneration and functional recovery of the nerve injured are almost never achieved.
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The peripheral nervous system (PNS) is composed of
the cranial nerves, which project from the brain and
pass through foramina (openings) in the scull, and the
spinal nerves, which project from the spinal cord and
pass through intervertebral foramina of the vertebrae
[1]. The PNS consists of motor and sensory neurons that
are the largest and most spatially complex in the body.
Peripheral nerve injuries are more frequent and may be
accompanied by neurological deficits. In contrast to the
central nervous system, the peripheral nervous system
has competence to regenerate injured axon [2]. It is es-
sential for clinicians to have an understanding of basic
anatomy of PNS in order to classify and subsequently
treat a nerve injury. Within the given peripheral nerve,
fibers are organized in separate bundles known as fasci-
cles. Less than half of the nerves are enclosed within* Correspondence: ymer_mekaj@hotmail.com
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unless otherwise stated.myelin sheaths. The remaining unmyelinated fibers
travel in deep gutters along the surface of Schwann cells
[3]. Schwann cells are the key element for the promotion
regeneration [4].
Regeneration of the damaged peripheral nerve depends
on the microsurgical procedure performed. Currently,
there are several operating techniques used to repair in-
jured nerves such as direct epineural repair, grouped
fascicular repair, fascicular repair, and nerve grafting.
The results following nerve repairs are influenced by
many parameters, such as the nature, location, and ex-
tent of the injury, the level and timing of the repair, the
fascicular anatomy, appropriateness of re-alignment of
the injured nerve, and the surgical technique, as well as
patient factors [5].
In addition to these factors in the regeneration of
nerve repair, some pharmaceutical agents which are usedtd. This is an Open Access article distributed under the terms of the Creative
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eral studies have shown that the most frequently applied
topical substances are tacrolimus (FK506), hyaluronic acid
and its derivatives, melatonin, and methylprednisolone.
These substances contribute to fibroblast proliferation
suppression at the site of the peripheral nerve repair thus
reducing scar formation in the injured peripheral nerve.Application of pharmacologic agents at the site
of peripheral nerve repair
Effects of topically administered FK506 on peripheral
nerve regeneration
Tacrolimus (FK506) is a macrolide immunosuppressive
drug that is approved for the prevention of allograft re-
jection. The abilities of tacrolimus are to modulate the
immune system and to inhibit T cell function by binding
to FK binding proteins (FKBP) and mediate immunosup-
pression by inhibiting calcineurin and calcium- and
calmodulin-dependent phosphatase. The primary biologic
effect of calcineurin inhibition includes the decrease of the
production of inflammatory cytokines such as tumor ne-
crosis factor (TNF)α, interleukin-2, and interferon-γ [6].
FK506 binds to its receptors. There are two types of re-
ceptors for FK506: FKBP12 and FKBP52. The FKBP12
receptors are responsible for immunosuppressive effects,
whereas the FKBP52 receptors are related to neuroregen-
erative effects. Studies performed during the past decade
have demonstrated FK506 in sub-immunosuppressive
doses exhibits neuroprotective and neuroregenerative
properties. This finding has stimulated interest in char-
acterizing the neurophysiologic effect of FK506 with
various nerve injury models [7]. FK506 has been proven
to have neurotrophic actions in experimental models,
increasing neurite elongation and accelerating the rate
of nerve regeneration in vitro and in vivo [8]. It has
been demonstrated that FK506, a generally applied im-
munosuppressant in organ transplantation, has a powerful
effect of promoting axon regeneration through its im-
munosuppressive and neurotrophic action [9-11]. The
topical effect of FK506 on peripheral nerve had not been
well investigated to date. Results of the use of FK506 in
peripheral nerve regeneration differ in the literature. One
possible reason for the relative variability of the results of
studies of experimental nerve injures is the variety of
models and testing methods used [12]. FK506 could pro-
mote peripheral nerve regeneration through reducing scar
formation; however, little is known about how FK506 re-
duces scar formation [13]. Prior studies have showed that
FK506-FKBP12 interaction may lead neuroregenerative ef-
fect through increased neuronal expression of a growth
cone-associated protein GAP-43, but there are evidence
that this occurs through inactivation of neuronal nitric
synthetase [14,15]. It is known that the key bindingprotein FKBP52 (also known as FKBP-59 or heat shock
protein) is responsible for neurotrophic action of FK506.
This (neurotrophic) action can be completely prevented
by the addition of monoclonal antibody against FKBP52
in vitro [7] A reduction in scar formation at the site of
nerve repair by the abovementioned mechanisms has been
associated with better nerve function recovery.
Effects of topically administered hyaluronic acid on
peripheral nerve regeneration
Hyaluronic acid (HA) is a carbohydrate, more specifically
a mucopolysaccharide, occurring naturally in all living or-
ganisms. It can be several thousands of sugars (carbohy-
drates) long. When not bound to other molecules, it binds
to water giving it a stiff viscous quality similar to “Jell-o”
[16]. Hyaluronic acid was discovered in bovine vitreous
humor by Meyer and Palmer in 1934 [17]. It is most fre-
quently referred to as HA due to the fact that it exists
in vivo as a polyanion and in the protonated acid form
[18]. The term “hyaluronan” was introduced in 1986 by
Endre Balazs to conform with the international nomencla-
ture of polysaccharides [19]. HA is an agent which is
known to reduce the extent of scar formation by inhibiting
lymphocyte migration, proliferation and chemotaxis gran-
ulocyte fagocitosis and degranulation, and macrophage
motility [20]. The predominant mechanism of HA is un-
known; in vivo, in vitro, and clinical studies demonstrate
various physiological effects of exogenous HA. Of these
effects, worth mentioning is its chondroprotective effects
in vitro and in vivo (orthopedic application). HA has also
been successfully used in ophthalmology, cardiovascular
system, dermatology, and wound healing [16]. HA is a
major component of the extracellular matrix, and it plays
an important role in the early wound healing process [21].
HA is an endogenous stimulator of interleukin-1 (IL-1)
production and IL-1 affects fibroblasts proliferation and
collagenase production [22]. Exogenous HA enhances
chondrocyte HA and proteoglycan synthesis, reduces the
reproduction and activity of proinflammatory mediators
and matrix metalloproteinases, and alters the behavior of
immune cells. These functions are manifested in the
scavenging of reactive oxygen-derived free radicals, the
inhibition of immune complex adherence to poly-
morphonuclear cells, the inhibition of leukocyte and
macrophage migration and aggregation, and the regula-
tion of fibroblast proliferation [23]. HA and its deriva-
tives may also promote regeneration of injured nerves
through realignment of the fibrin matrix, and they can
provide a suitable environment for axonal ingrowth.
Use of the hyaluronic acid-carboxymethylcellulose (HA
CMC) membrane Seprafilm as a solid anti-adhesion
barrier agent is one of the therapeutic approaches to
deduce postoperative scar formation and is effective in
promoting peripheral nerve regeneration at the repair
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after type nerve injured [26]. Mohammad et al. describe
the early effect on nerve regeneration of continuous local
delivery of nerve growth factor (NGF) and the local in-
corporation of HA inside a newly manufactured nerve
conduit material from fresh human amniotic membrane.
Human amniotic membrane contains important biochem-
ical factors that play a major neurotrophic role in the
nerve regeneration process [27].
Effects of topically administered melatonin on peripheral
nerve regeneration
Melatonin (MLT) is the main hormone of the pineal
gland. The pineal gland is in the middle of the brain, and
it secretes MLT, a hormone that regulates when you sleep
at night and wake up in the morning [28]. Melatonin has
an effect on the morphologic features of the nerve tissue,
suggesting its neuroprotective, free radicals scavenging,
antioxidative, and analgesic effects in degenerative dis-
eases of peripheral nerves. At present, it is widely accepted
that melatonin has useful effect on axon length and
sprouting after traumatic events to peripheral nerves
[29,30]. As superoxide dismutase is an important antioxi-
dative enzyme involved in redox regulation of regulative
stress, melatonin would exert its beneficial effects by
preserving the superoxide dismutase reactivity follow-
ing peripheral nerve injury [31]. Melatonin would exert
its neuroprotective neurons after peripheral axotomy,
since it is known to reduce the oxidative damage in a
variety of experimental neuropathologies, in which nitric
oxide (NO) is involved [32]. Melatonin is believed to work
via electron donation to directly detoxify free radicals such
as the highly toxic hydroxyl radical [33]. The neuronal
isoform of nitric oxide synthetase (nNOS), a NADPH-
dependent diaphorase, is considered to play a role in
motoneuron death induced by sciatic nerve transaction.
Based on evidence, melatonin has strong antioxidant
and cell-protective effects via mimicking the effects of
calcium channel blockers [34]. Rogerio et al. have found
that melatonin at doses of 1 to 50 mg/kg decreased
neuronal death, whereas doses of 50 to 100 mg/kg
caused failure to thrive, seizures, or death [35]. Turgut
et al. have demonstrated the effect of melatonin in pre-
venting neuroma formation of transacted sciatic nerve
in rats. Melatonin enhanced axonal regeneration due to
its inhibitory effect on neuroma formation [36]. Periph-
eral nerve injury that requires surgical repair does not
result in complete recovery because of collagen of scar
formation, ischemia, free oxygen radical damage, and
other factors [34]. Although there are great numbers of
studies that have mentioned protective effects of mela-
tonin on peripheral nerve pathologies, there are also
some studies that report toxic effects of melatonin on
peripheral nerves [29].Effects of topically administered methylprednisolone on
peripheral nerve regeneration
Methylprednisolone has been intensely investigated. Be-
cause of its pharmacological properties, it is considered
to be neuroprotective. A primary neuroprotective mech-
anism of action in each of these cases is hypothesized to
involve the ability of high doses of methylprednisolone
to inhibit oxygen free radical-induced lipid peroxidation,
although additional mechanisms may contribute [37].
Topically administered dexamethasone on peripheral
nerve offers the benefit of cost savings as well as avoiding
the complications associated with systemic administration.
Dexamethasone loaded in silicone tube can improve func-
tional recovery and morphometric indices of sciatic nerve
[38]. Nachemson et al. have reported that methylpredniso-
lone suppresses scar formation and improves axonal re-
generation after transaction and suture of rat peripheral
nerves [39]. Boa et al. have reported that methylpredniso-
lone in early treated rats has reduced lipid peroxidation
and inhibited arachidonic acid hydrolysis following spinal
cord injury [40]. Suslu et al. have evaluated the effect of
preoperatively locally administered dexamethasone on
nerve recovery after induced nerve crush injury, and they
concluded that local dexamethasone is more effective than
systemic dexamethasone [41]. Dexamethasone and vita-
min B12 are currently used in the clinic to treat peripheral
nerve damage, but their mechanisms of action remain in-
completely understood. Sun et al. concluded that dexa-
methasone and vitamin B12 promote peripheral nerve
repair in a rat model of sciatic nerve injury through the
upregulation of brain-derived neurotrophic factor (BDNF)
of expression [42].
Effects of topically administered vitamin B12 on
peripheral nerve regeneration
B vitamins were reported to attenuate degenerating
processes in the nervous system and therefore have
been clinically administered in a combination of B1
(thiamine), B6 (pyridoxine), and B12 (cobalamine; Cbl)
[43]. Vitamin B12 is a micronutrient that plays signifi-
cant roles in numerous biological processes. B12 defi-
ciency leads to methionine deficiency which required
for the synthesis of both phospholipids and myelin. In
addition, vitamin B12 has shown antioxidant properties
[44]. Okada et al. showed that vitamin B12 provides a
basic for more beneficial treatments of nervous disor-
ders through effective systemic or local delivery of high
doses of methylcobalamin to target organs [45]. Vita-
min B12 is also a good scavenger of the reactive oxygen
species and is suggested to be a good neuroprotectant.
Hobenaghi et al. revealed that the regeneration and
healing in dorsal spinal ganglion will be improved by
increase of administration time and vitamin B12 dose,
indicating that such vitamin was able to progress
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mental rats [46].
Methods used for evaluating the success of the
regenerative process after nerve repair in
experimental research
There are several methods for evaluating peripheral
nerve regeneration after nerve repair: morphologic, elec-
trophysiological, biochemical, and functional methods.
These methods can be performed with a large number
of anatomic techniques that can provide new insights
into the process of peripheral nerve regeneration [47].
Morphological method
Morphological analysis is the very common method for
the study of the peripheral nerve regeneration [48]. The
morphometry method serves to describe structures in
quantitative terms and in particular reveals minimal
morphological differences between states of function
[49]. Quantitative estimation of nerve fiber morphology
and functional assessment is a very important tool in
nerve regeneration research. Raimondo et al. mentioned
eight geometrical parameters that can be used for the as-
sessment of nerve fibers, which are number of fibers,
density of fibers, diameter of fibers and axon, myelin
thickness, myelin thickness/ratio and fiber diameter/axon
diameter ratio or axon diameter, and fiber diameter/axon
diameter ratio or axon diameter/fiber diameter (g-ratio)
[50]. It is known that g-ratio equals 0.6, which approxi-
mates average values observed in most nerves; the rela-
tionships are theoretically optimal to the spread of current
on the node of Ranvier to the next [51]. Count and meas-
ure of myelinated fibers can be performed with manual or
current digital technique (automatic) [52]. It is well known
that manual morphometry is difficult to perform and re-
quires more time, whereas fully automatic computerized
image analysis system is more precise and far less time
consuming. Histograms of myelinated fiber size and
median fiber diameter provide quantitative date on the
regenerative process. Through electron microscopic
photographs, we can obtain a detailed view of cell or-
ganelles and laminar structure of myelin and small un-
myelinated fibers. Immunochemistry method can be
used to evaluate axon regeneration in the early phase
after injury [53]. According to Santos et al., the quanti-
tative parameters of nerve fibers can vary significantly
depending on the nerve level and on the distance from
the point of lesion [54]. Therefore, the average values
obtained from measurements made in different seg-
ments of the nerve should be calculated. Studies sug-
gest that there is no single morphological technique
which can be considered superior for the evaluation of
peripheral nerve regeneration [55]. However, it is im-
portant to choose the appropriate methods for specificexaminations in the context of examining the structure of
nerve. Also, it is important to consider the cost benefit ra-
tio for the selected method. Histomorphometry is often
the final step of morphological investigation. Although ap-
parently, simple quantitative morphology is tricky and
should be carried out carefully in order to avoid the bias
creeps in to the estimates [56]. Although there is a positive
correlation between morphological and functional param-
eters of nerve regeneration, occasionally, this correlation
is absent or is not satisfactory.
Electrophysiological evaluation
For the assessment of the regeneration and functional
restitution after nerve injury, electrophysiological tests
should be applied. These tests are commonly used in
clinical practice and can also be performed in animal
models. Electrophysiological tests provide a quantita-
tive measurement in the normal and pathological state.
Neurological studies with the peripheral nerve injuries
involved and integrated approach using sensor and
motor nerve conduction studies and electromyography
(EMG), as well as motor- and sensory-evoked poten-
tials in some instances, as helpful adjuncts to the clin-
ical assessment [57]. These tests are commonly used in
clinical practice and can be also performed in animal
models to determine the nature of the disorders and
their severity. EMG serves to evaluate the motor unit
action potentials (MUAPs) [58].
Nerve action potential (NAP) recording is a proven
and useful tool in the surgical management of nerve in-
jury [59]. The evoked action potential of individual
axons has a characteristic spike waveform and conduc-
tion velocity (CV), which are dependent on the type of
nerve fiber (diameter and myelination) and physiological
state (temperature, metabolism) [60]. Two extracellular
recording electrodes pick up the maximally evoked elec-
trical activity of all active fibers, giving a summed potential
called a compound nerve action potential (CNAP) [53].
CV and amplitude of compound muscle action potential
(CMAP) are used as indicators for neural regeneration
[61]. CMAP represents the summation of the action po-
tentials of all the excited muscle fibers that respond to the
nerve stimulation. Therefore, motor nerve conduction
tests provide selective information on the function and re-
generation of α-motor axons [58]. Each wave of CV can
be calculated by measuring the latency of the distance be-
tween stimulating and recording electrode. In regenerative
nerves, the CV is altered by changes in axon diameter and
myelination and remains below normal value for a long
time after successful regeneration. The CNAP amplitude
does not correlate with a total number of regeneration
myelinated fibers, but has a highly significant relation fol-
lowing an exponential function, which is the number of
large myelinated fibers [62].
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often used for evaluation of neural regeneration because it
is an invasive method. However, it is suitable for longitu-
dinal measurements using appropriate recording device.
Neurophysiological measurements ex vivo enable higher
reproducibility and signal quantification as compared to
in vivo measurements due to several factors that can
change, such as distance, temperature, etc. The degree of
the damaged nerve can be estimated by comparing the
electrophysiological values between the damaged nerve
and the respective contralateral nerve.
Motor nerve conduction tests
According Fullerton and Barnes 1966, motor nerve con-
duction is a widely used electrophysiological technique,
which serves for assessment of nerve regeneration and
neuropathies in experimental models since in the 1960s
[63]. These tests have a larger amplitude potential than
direct nerve conduction tests. The amplitude of the
CMAP is determined by the number of muscle fibers
innervated. In contrast to the CNAP, the CMAP ampli-
tude is little affected by the distance of the conduction.
The motor CV can be calculated in the nerve segment
between two stimulation sites by dividing the difference
of the latencies by the distance between the stimulation
points. The CMAP amplitude is proportional to the
number of motor axons regenerated and the side for
the corresponding motor units in the recorded muscle
[58]. It is known that complete recovery of the ampli-
tude does not show that all axons in the injured nerve
are regenerated.
Functional evaluation of the nerve repair
There are several tests for functional evaluation of the
nerve repair. In aadition to the large variety of electro-
physiological and morphological tests for studying nerve
regeneration in animals, there are several other tests for
the functional evaluation of nerve repair. One of the best
known tests is the sciatic function index (SFI) in rats.
For rabbits, the toe-spreading reflex has been suggested
as a valuable index for peroneal function [64]. Many
experiments on nerve regeneration are performed in
recent years using SFI as a measure of functional loss.
According de Medinaceli et al. (1982), there are a wide
variety of techniques that can be used to study the re-
covery of the peripheral nerve injury, but it should be
taken into consideration that unlike in, humans these
techniques are difficult to perform in animals [65].
Nerve regeneration in animal experiments can be
assessed with histomorphometry and electrophysiology
measurements; however, these methods do not always
correlate with recovery motor and sensory functions
[66]. It is recommended to use various methods for
overall assessment of nerve function [67]. One of thesemethods is a walking track which was designed to
visualize and record gait of rats. Rats were allowed to
walk freely in a walkway in order to analyze their visible
footprints by stepping in developer on X-ray film or paint
on paper [65]. Bervar introduced a new method that can
perform credible and fast footprint analysis [68]. For
evaluation of the footprints, three different parameters are
used: print length (PL), toe spread (TS), and intermediary
toe spread (ITS) [69].Conclusion
Traumatic injuries of the peripheral nerves are very com-
mon. Surgical repair of the damaged nerve is often com-
plicated by scar tissue formation around the damaged
nerve. Numerous data from literature suggest that in
order to prevent scar formation, topical pharmacological
agents at the site of peripheral nerve repair can be applied.
In this review paper, we presented some of the most com-
monly used pharmacological agents in animal models.
These pharmacological agents prevent scar formation at
the site of peripheral nerve repair and accelerate nerve re-
generation. The mechanisms of action by which these
substances operate in peripheral nerve regeneration are
described in detail. There are several methods for nerve
repair evaluation following topical application of different
pharmacological agents, such as morphometry, electro-
physiology methods, and walking track analysis. These
methods are of great value in functional assessment of the
damaged nerve. In summary, topical pharmacological
agents have a notable effect in the prevention of scar tis-
sue formation and contribute markedly in nerve regener-
ation. It is understandable, however, that complete
regeneration and functional recovery will almost never be
achieved.
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